DX / Differentials / ORTHOPEDIC & MSK
D-01 — PATIENT ACQUISITION COST · ORTHOPEDIC & MSK
Cost per new patient is climbing — orthopedic and MSK
Cost per new patient is rising and the two halves of the business are being averaged
PRESENTATION — WHAT THE OPERATOR SEES
Cost per new patient is climbing and the marketing budget is being defended on a number that mixes two businesses. Orthopedic and MSK demand arrives two ways — direct, at the clinic front door, and referred, into the operating room — and averaging them produces a figure that describes neither. Establish the split before diagnosing anything else.
DIFFERENTIAL — LIKELY CAUSES, MOST LIKELY FIRST
- 01
Direct and referred patients are pooled into one cost
Media buys direct patients. It does not buy referred ones, and a referral arriving in the same month is credited against the same spend. As the referral mix moves, the blended cost per new patient moves with it, for reasons that have nothing to do with what anything cost.
The direct-versus-referred split is recorded at intake in most groups and is almost never carried through to the marketing report. That absence is the finding.
No published distribution — ADMEN source register, /sources/
NOT THIS IF — New patient visits are already reported split direct versus referred and the rise is confined to the direct half.
- 02
The cost was built from ad dashboards rather than from the ledger
A dashboard reports media cost. It does not report agency fees, production, call handling, listings management or the liaison salaries that belong to the referral half. A cost per new patient built from the platform understates the real one every time, and the understatement grows as non-media spend grows.
The ledger and the vendor invoices already carry the full number. Rebuilding the cost line from them is arithmetic, not research.
No published distribution — ADMEN source register, /sources/
NOT THIS IF — The cost line is already reconciled to the general ledger monthly.
- 03
Access time collapsed the conversion and the money is being spent to replace it
A patient in pain takes the first credible provider who can see him quickly. When the wait for a new patient appointment lengthens, the same media buys the same clicks and fewer patients — which arrives at the finance meeting as a price rise.
Time to next available new patient appointment, per clinic and per provider, is a schedule query. It is rarely reported to whoever buys the media, which is the only place it would change a decision.
No published distribution — ADMEN source register, /sources/
NOT THIS IF — Time to next available appointment held steady across the period at every clinic.
- 04
Condition mix shifted toward the more expensive lines
Spine, joint replacement and sports medicine do not cost the same to acquire. A shift in the mix moves the blended figure without any auction price changing at all, which is why demand bought by condition line is the only version of this number that stays legible.
Cost per new patient by condition line is buildable from the group's own booking and billing data, and is what makes a mix shift visible instead of mysterious.
No published distribution — ADMEN source register, /sources/
NOT THIS IF — Cost per new patient rose inside every condition line individually.
HOW TO TELL THEM APART
How to tell these apart in your own numbers
Each of these is a measurement you can run yourself, without us.
01 · Direct and referred patients are pooled into one cost
New patient visits per clinic per month, split direct versus referred, twenty-four months, with spend allocated only against the direct half.
CONFIRMS IF
The direct-only cost is flat or falling while the blended figure rises, or the referral share moved materially.
EXCLUDES IF
The direct-only cost rose on its own.
02 · The cost was built from ad dashboards rather than from the ledger
Rebuild twelve months of cost per new patient from the general ledger and vendor invoices, then compare against the dashboard-derived figure.
CONFIRMS IF
The ledger figure is materially higher, or the gap between the two is widening.
EXCLUDES IF
The two reconcile inside a few per cent.
03 · Access time collapsed the conversion and the money is being spent to replace it
Time to next available new patient appointment by clinic and provider, weekly, plotted against clicks-to-booked-visit conversion over the same weeks.
CONFIRMS IF
Conversion falls as the wait lengthens, and the clinics with the longest waits carry the worst cost.
EXCLUDES IF
Wait times held and conversion fell anyway.
04 · Condition mix shifted toward the more expensive lines
Cost per new patient by condition line — knee, hip, shoulder, spine, foot and ankle, sports injury — twenty-four months.
CONFIRMS IF
Each line is inside its own trailing range and the blended number moved because the mix did.
EXCLUDES IF
Cost rose within every line.
WHAT RESOLVES EACH
What resolves this, and how you will know it resolved
| Direct and referred patients are pooled into one cost | Rx 04 · marketing attribution → | New patient visits reported split direct versus referred from the first month, with spend allocated only against the half it can affect. What does not work: cutting media on a blended number. It changes the figure and not the business. |
| The cost was built from ad dashboards rather than from the ledger | Rx 04 · marketing attribution → | The cost line rebuilt from the ledger and vendor invoices rather than from ad dashboards, reconciled monthly. |
| Access time collapsed the conversion and the money is being spent to replace it | Rx 03 · patient conversion → | Access instrumented as a marketing input — measured per clinic and per provider, reported next to volume, and used to decide where demand is directed. |
| Condition mix shifted toward the more expensive lines | Rx 01 · patient acquisition → | Demand bought and read by condition line, each with its own cost per new patient, so a mix shift is legible instead of alarming. |
WHAT "RESOLVED" LOOKS LIKE — Cost per new patient, direct half only, by condition line, built from the ledger
MEDIAN
Not published. No orthopedic or MSK acquisition-cost distribution has been read in a primary source.
TOP DECILE
Not published, and a vendor figure is not a substitute. A vendor with a product to sell is not a denominator.
TARGET
The group's own trailing twenty-four months, rebuilt on the direct-only denominator and split by condition line. Resolved means the direct-half figure is flat or falling while direct visits rise.
No published distribution — ADMEN source register, /sources/
HOW THIS DIFFERS BY SCALE
How this differs by scale
| Single site | One clinic, one schedule. Access time and the direct-versus-referred split are the whole diagnosis. |
| Group | The split moves between sites, so a group figure without it is an average of two different businesses in different proportions at every clinic. |
| Platform | With an ambulatory surgery centre attached, the cost per new patient question is really a cost per case question, and the pipeline between them has usually never been drawn. |
OTHER PRESENTATIONS — ORTHOPEDIC & MSK
- New patient visits are short and the schedule is the reason
- Visits are flat and the cases are where the money is
- One playbook, and clinics that behave nothing alike
- Visits are documented and the case pipeline is not
A differential narrows the field. It does not replace the examination — that is what the six weeks are for. Every figure above is an industry reference range, not a client's numbers; those stay sealed. Sources are set out at /sources.
APPLY — 6 / QUARTER →